Healthcare Pharma & Life Sciences Other Industries
All Services Performance Marketing ChatGPT Ads India · NEW Social Media Marketing SEO & AEO / LLM YouTube Marketing LLM Optimization Brand & Growth Consulting AI Solutions Industries We Serve
Enterprise Hub · All Solutions + Services Growth Transformation AI Transformation Revenue Operations Fractional CGO Growth Operating System Executive Growth Advisory
Clinic Launch Programme (Hub) NABH Consulting India Healthcare Brand Launch Clinic SOP Creation Logo Design (Healthcare) Brand Book Creation Clinic Launch Marketing D2C Brand Launch Clinic Interior Design
Workforce Hub For Employers — post a requirement For Professionals — register Public Openings Training Academy AI Training Flagship
Hawk · CRM Intelligence (NEW) YODA · YouTube Intelligence Angryturtle · GBP Intelligence (NEW) Prism Pulse · Instagram Analytics (NEW) Beacon · Attribution Agency OS · Dashboards Phoenix · Clinic Revenue HealthPro 360 · PMS/HMS AI Patient Lifecycle Bots AI Lead Management System Smart Appointment System Healthcare CRM Patient Feedback System AI, Analytics & Automation Digital Transformation Calculators Free Digital Health Audit →
All 13 calculators → 🎯 Business Exploration Matrix (New) Dental Clinic Setup IVF Clinic + Lab Setup Multi-Specialty Hospital Setup Aesthetic / Cosmetology Clinic Dermatology Clinic Setup Generic Clinic Setup Physiotherapy Clinic Setup Diagnostic Centre Setup CAC Calculator CPQL Calculator Franchise ROI Calculator Revenue Leakage Calculator CRM ROI Calculator
All Events Workshop 1 · Jun 13 · AI in Clinical Practice Workshop 2 · Jun 27–28 · AI in Growth & Governance Hospital Ops Workshop · Jul 12 Pre-Summit Seminar · Aug 16 Grand Summit 2.0 · Oct 10–11 Bihar AI Summit · Recap AI Innovation Awards · Aug 22 Grand Summit 2.0 · Oct 2026 Aarambh 2026 Recap
Case Studies Insights & Blog Research Reports Calculators AI in Healthcare Digest
Our Story Leaders @ Ichelon · IN · US · AU Ichelon India · Gurgaon Ichelon Consulting US · Dallas, TX Ichelon Australia · Sydney Speakers & Panelists Client Elevation Programme 🤝 Partner Connect 🇦🇪 ICG UAE Careers
Book a Growth Diagnostic →
We Do It Right. The right diagnosis. The right strategy. The right systems. Giving healthcare leaders the confidence to make better decisions, build stronger operations, and achieve sustainable growth. — Team Ichelon
State medical board series · New York · 2026

New York medical board advertising rules — the marketing compliance guide

A working guide to New York physician advertising and referral rules under Education Law Section 6530, the Office of Professional Medical Conduct (OPMC), and the State Board for Medicine. Written for New York practice owners, in-house marketing leads and agencies delivering paid, organic, review and content programs to New York-licensed physicians and dentists.

Education Law 6530
Professional misconduct definitions for New York physicians
OPMC
Office of Professional Medical Conduct — investigates complaints
Referral controls
PHL 238-a and Section 6530(18)-(19) — fee-splitting and referral bans
Direct answer
  • New York physician advertising sits inside a broader professional misconduct framework at Education Law Section 6530. Advertising rules are one category (Section 6530(27)); referral and fee-splitting rules are another (Section 6530(18)-(19)). A marketing decision often crosses both.
  • Discipline is handled by the Office of Professional Medical Conduct (OPMC), an arm of the New York State Department of Health. Cases with findings are adjudicated by hearing panels of the Board for Professional Medical Conduct and determinations become public.
  • New York has one of the more restrictive physician referral and fee-splitting regimes in the country. Public Health Law 238-a restricts self-referral for designated health services, and Section 6530(19) prohibits fee-splitting arrangements that most other states leave to federal Anti-Kickback / Stark analysis. Referral-bounty marketing structures need explicit legal review in New York.
  • Advertising is regulated on a truthful-and-not-misleading standard identical in principle to other states, but the enforcement mechanism is different — professional misconduct findings attach to a physician's licence and enter a public determination record.
  • New York does not pre-approve advertising. Complaint-driven enforcement is the model, and OPMC investigations often intersect with parallel review by the Attorney General's Health Care Bureau on consumer-protection grounds.
Not legal advice. This is marketing guidance reviewed against current New York State Board for Medicine and OPMC rules. Consult a healthcare-marketing attorney licensed in New York and confirm any specific claim with the relevant board before publication.
The ICG engagement model
Every practice welcome — retainers starting from $499/mo.
Goals-Driven engagements · Performance-Linked Payout Models available. Read the full engagement model →
🎯 Ichelon Agency OS See your goals live · client-facing dashboard, updated in real time. Click any screenshot to zoom. Open the full engagement model →
Trusted by US practices · case studies → 8 live practices · TX · CA · VA · nationwide telehealth
Dr. Rajan Kohli
Owner, Lakewood Primary Care & Wellness · North Dallas, TX
Client video · Practice website build
“They were able to get all my ideas and work with me over a period of three to four months and create this amazing website. It's super customized, very modern, and it incorporates all the elements that I had wanted — the patient portal, nice pictures, a very interactive website, patient reviews. I would highly recommend their company to anyone who wants to make an excellent website.”
Dr. Rajan Kohli Owner, Lakewood Primary Care & Wellness · North Dallas, TX
Regulator map

Which agencies actually regulate New York physician advertising

New York's medical regulation is structurally different from most states. Licensure and admission to practice sit with the New York State Education Department Office of the Professions, under the umbrella of the Board of Regents. Discipline of licensed physicians for professional misconduct — the category that captures false or misleading advertising — is handled by the Office of Professional Medical Conduct (OPMC), an arm of the New York State Department of Health. The State Board for Medicine, a professional board within the Education Department, provides expert peer input into both licensure and discipline processes.

Dentists sit under a parallel structure: licensure through the Office of the Professions, discipline through the Board of Regents and the State Board for Dentistry. The Board of Regents exercises ultimate disciplinary authority in the dental profession, whereas OPMC's authority is specific to physicians, physician assistants and specialist assistants. Optometry, chiropractic, physical therapy and other healing-arts professions run under the Office of the Professions and their respective state boards for both licensure and discipline.

The federal baseline still applies universally: HIPAA governs Protected Health Information in every marketing communication, the FTC Act governs truthful advertising, TCPA covers outbound calls and SMS to New York numbers, CAN-SPAM covers email, and ADA / Section 508 covers accessibility. New York layers on three things worth internalising.

  • Professional misconduct framing. Advertising violations are handled as misconduct against a licence, not as consumer-protection actions against a business. That changes the risk calculus: a finding attaches to the physician's licence and to their permanent determination record, not just to the practice entity.
  • Restrictive referral and fee-splitting regime. New York's referral rules under Public Health Law 238-a and Section 6530(18)-(19) are stricter than the federal Stark / Anti-Kickback baseline in specific respects, and referral-bounty marketing structures need explicit review.
  • Parallel Attorney General consumer-protection jurisdiction. The New York AG's Health Care Bureau exercises consumer-protection jurisdiction over health advertising and has been active on misleading claims, hidden fees, and deceptive telehealth marketing.
Citation: New York Education Law Article 131 (Medicine); Education Law Section 6530; Public Health Law Section 238-a; Office of Professional Medical Conduct enforcement.
The core statute

Education Law Section 6530 — the professional misconduct spine

Section 6530 lists the acts and omissions that constitute professional misconduct for a New York-licensed physician. Two clauses matter most for a marketing team: 6530(27), which addresses advertising, and 6530(18)-(19), which address referral, fee-splitting and remuneration.

Section 6530(27) — advertising

Section 6530(27) captures advertising or soliciting for patients in a manner that is false, fraudulent, deceptive, misleading, sensational, or flamboyant. The list of adjectives — sensational and flamboyant in particular — reads broader than most state advertising rules and gives OPMC latitude that a strict truthful-and-not-misleading standard would not. In practical enforcement, "sensational" and "flamboyant" tend to be applied where the underlying claim would fail the truthfulness test anyway, but they can matter in aesthetic and elective-surgery contexts where advertising tone alone can trigger review.

The truthfulness and non-deception standard is enforced against a reasonable-consumer test. A statement can be technically accurate and still deceptive if it is arranged to create a false impression. Omission of a material fact — the qualifying conditions on a promotion, the credentials that support a specialty claim, the delegation structure behind a procedure — is a Section 6530(27) violation on the same footing as an affirmative false statement.

Section 6530(18)-(19) — referral and remuneration

Sections 6530(18) and 6530(19) prohibit specific referral and remuneration patterns. Section 6530(18) captures directly or indirectly requesting, receiving or participating in the division, transference, assignment, rebate, splitting or refunding of a fee for professional services. Section 6530(19) captures paying or accepting rebates or kickbacks for referring patients. These provisions are enforced strictly and matter to marketing arrangements more than practitioners often realise.

  • A referral-bounty marketing program that pays a marketing partner a per-patient fee for New York patients acquired risks a Section 6530(19) finding.
  • A revenue-share arrangement with an aggregator that scales with New York patient volume risks a Section 6530(18) finding.
  • A cross-promotion between a New York physician and an ancillary service provider needs to be structured so that no payment moves per patient referred.
Common New York enforcement pattern. A marketing agency structures a "pay-per-patient" or "pay-per-lead" arrangement with a New York-licensed clinic. Even where the underlying advertising is truthful, the compensation structure implicates Section 6530(18)-(19) and Public Health Law 238-a. The clean structure is a flat-fee retainer for marketing services, not a per-patient bounty.
Delta vs federal

What's different from the federal HIPAA / FTC baseline

New York layers three specific things on top of the federal HIPAA/FTC/AKS/Stark baseline that a marketing team should internalise.

  • Stricter fee-splitting and referral regime. Federal Anti-Kickback (42 USC 1320a-7b) and Stark (42 USC 1395nn) apply to federal-payer arrangements. New York's Section 6530(18)-(19) and Public Health Law 238-a apply regardless of payer and reach further into commercial arrangements. A structure that clears federal AKS may still fail Section 6530(19).
  • Professional misconduct enforcement. Federal FTC actions are typically corporate. New York disciplinary actions attach to a physician's licence. The reputational and career impact is different, and often heavier.
  • "Sensational or flamboyant" standard. The Section 6530(27) list of adjectives reaches beyond the strictly truthful-and-not-misleading standard of the federal FTC Act and most sister-state statutes. It matters in elective and aesthetic advertising, where tone alone can put a campaign in front of an investigator.

A New York-specific review therefore checks three things a federal review does not: does the compensation structure survive Section 6530(18)-(19), does the tone of the ad survive the sensational/flamboyant standard, and does the licensed physician remain the responsible party for every advertised service.

Cross-reference: 42 USC 1320a-7b (Anti-Kickback); 42 USC 1395nn (Stark); NY Education Law 6530; NY Public Health Law 238-a.
Referral controls

New York-specific referral, self-referral and fee-splitting rules

Referral marketing structures deserve a dedicated section because they are where a New York advertising review most often lands its findings. Three distinct provisions attach.

Public Health Law 238-a — the self-referral rule

PHL 238-a restricts a New York practitioner from referring patients for clinical laboratory services, pharmacy services, radiation therapy, and physical therapy services to a facility with which the practitioner has a financial relationship, unless a statutory exception applies. Marketing structures that route New York patients into a referral pattern touching these designated health services need explicit legal review because a marketing arrangement can itself constitute the "financial relationship".

Section 6530(18) — fee-splitting

Section 6530(18) prohibits directly or indirectly participating in the division, transference, assignment, rebate, splitting or refunding of a fee for professional services. A percentage-of-revenue marketing engagement that maps to referrals of professional service revenue triggers analysis under this provision.

Section 6530(19) — kickbacks for referrals

Section 6530(19) prohibits paying or accepting kickbacks for referring patients. This is the provision that most directly reaches lead-generation and pay-per-lead marketing structures. Compensation that scales with New York patient acquisition — as opposed to marketing effort or service delivery — is exposed.

Clean marketing engagement structure for New York. Flat monthly retainer for defined marketing services (paid search management, content production, review-response operations, GBP management) · deliverables independent of patient acquisition · no per-patient bounty · no revenue-share tied to referrals of designated health services · written engagement agreement reviewed by New York-licensed counsel.
Credentials

Specialty designation and credentials in New York

New York, like most states, requires that "specialist" and "board-certified" be reserved for physicians actually recognised in a specialty by an ABMS member board, an AOA-affiliated board, or a certifying body accepted by the Board of Regents. Practice-focus language ("our practice focuses on cardiology") is permitted; specialist and board-certified language is regulated.

Provider directory accuracy is the single most common source of stale-credential findings in New York, as in most states. A physician who leaves a group but remains on the group's provider directory beyond a reasonable transition window creates a misleading representation. Monthly reconciliation between credentialing and marketing is the practical control.

Advertising the location of practice is straightforward provided each named location is actually staffed by the physician on the days advertised and the licensed facility is authorised to provide the services described. Multi-location advertising that suggests capabilities not actually available at a specific location is a misleading omission under Section 6530(27).

Adjacent professions

Dentistry, chiropractic and adjacent professions

New York dental advertising sits under the State Board for Dentistry and the Board of Regents, with rules functionally similar to the physician rule set: truthful, not misleading, no deceptive omissions, specialty designation only in ADA-recognised specialties. Corporate practice of dentistry in New York routes through Professional Service Corporations, and advertising must identify the professional entity providing dental care, not just a marketing brand.

Chiropractic advertising sits under 8 NYCRR Part 73 and the State Board for Chiropractic. Optometry sits under 8 NYCRR Part 66 and the State Board for Optometry. Physical therapy sits under 8 NYCRR Part 77. In each case, the advertising rule mirrors the physician rule in spirit and adds profession-specific specialty designations and scope-of-practice constraints on what the licensee may advertise doing.

Cross-referral arrangements between New York physicians and adjacent professionals (chiropractors, physical therapists, imaging providers) sit at the intersection of Section 6530(18)-(19), PHL 238-a, and the parallel provisions in the referring profession's rule set. A joint-marketing arrangement that appears to be a professional courtesy can still fail if compensation moves per patient referred.

Reviews and testimonials

Reviews, testimonials and the NYC market

New York City accounts for a disproportionate share of state advertising volume, and the review landscape — Google, Yelp, ZDoc-style aggregators — is where most patients form their first impression. The rules that attach to reviews in New York mirror the pan-US pattern with a New York-specific twist.

  • Solicited testimonials require a signed HIPAA marketing authorisation covering the specific quote, image and media, plus a "results not typical" disclosure where the outcome is atypical, plus a material-connection disclosure where compensation moved.
  • Responses to public reviews must not confirm the treatment relationship, name procedures, or discuss outcomes. Confirmation is a HIPAA disclosure to the platform and every reader.
  • The New York Attorney General's Health Care Bureau has been active on fake-review practices. A campaign that solicits, buys or generates reviews without underlying genuine patient experience risks parallel consumer-protection action in addition to Section 6530(27) exposure.
Sanctioned review response pattern (New York). "Thank you for taking the time to share your experience. Our team is grateful for the feedback. If there is anything we can do, please reach out to us directly." No name, no procedure, no outcome, no treatment confirmation. Applied consistently across Google, Yelp, and other platforms.
Operating model

What a New York-licensed practice should build in-house

Section 6530 checklist

Every campaign clears the 6530(27) advertising standard and the 6530(18)-(19) referral standard before publication. Named reviewer signs off. Two-signature rule for elective and aesthetic content.

Engagement-structure audit

Marketing engagements audited annually to confirm no per-patient compensation, no revenue-share on professional services, no fee-splitting exposure. Written retainer terms filed and dated.

Referral map

A shared map of every referral relationship, tagged for PHL 238-a exposure. Any relationship touching designated health services is reviewed by New York-licensed counsel before promotion.

Provider directory reconciliation

Monthly reconciliation between credentialing and marketing. Physician profile pages match the current New York licence, active certifications, and scope of practice on the day the page is served.

Testimonial pipeline

Genuine, substantiated, disclosed for typicality, disclosed for material connections, HIPAA-authorised, and retained for six years. Public review responses standardised on a sanctioned pattern.

Retention and archive

Six-year retention on advertising materials, substantiation files, marketing authorisations, and engagement agreements. Retrievable in under 48 hours if OPMC or the AG's Health Care Bureau serves a request.

Compliance stack

Where New York rules sit in the wider compliance stack

A New York-licensed practice publishing marketing content clears the federal baseline (HIPAA, FTC, TCPA, CAN-SPAM, ADA) and the New York overlay (Section 6530, PHL 238-a, OPMC discipline, Attorney General consumer-protection jurisdiction) on every campaign.

Education Law 6530 PHL 238-a OPMC discipline HIPAA TCPA CAN-SPAM FTC endorsements Federal AKS & Stark ADA WCAG 2.2 AA
Marketing guidance, not legal advice. This page reflects Ichelon Consulting US's operating standard for New York-licensed healthcare marketing engagements. It does not constitute legal advice. Consult a healthcare-marketing attorney licensed in New York and confirm any specific claim with the State Board for Medicine or OPMC before publication.
FAQ

New York medical advertising — common questions

Which agency actually regulates physician advertising in New York?

Licensure runs through the State Education Department Office of the Professions. Discipline — including for false or misleading advertising — is handled by the Office of Professional Medical Conduct within the New York State Department of Health. The State Board for Medicine provides peer input.

What does Education Law Section 6530 say about advertising?

Section 6530 defines professional misconduct. Section 6530(27) covers advertising that is false, fraudulent, deceptive, misleading, sensational or flamboyant. Sections 6530(18)-(19) cover fee-splitting and improper referral practices.

Are New York patient testimonials regulated?

Yes. Testimonials that create false or unjustified expectations, describe atypical results without disclosure, or fail to disclose material connections are misleading under Section 6530(27). HIPAA marketing authorisation is required in addition to the state rule.

How does New York handle physician referral practices?

New York has a specific anti-kickback framework at PHL 238-a and Education Law 6530(18)-(19). Marketing arrangements structured as per-patient bounties or revenue-share on professional services trigger analysis under these provisions.

Can a New York physician advertise as a specialist?

Only in a specialty recognised by an ABMS member board, an AOA-affiliated board, or a certifying body accepted by the Board of Regents. Practice-focus language is permitted; "specialist" and "board-certified" are regulated.

What is OPMC and how does it work?

The Office of Professional Medical Conduct investigates complaints against New York-licensed physicians and adjacent licensees. Cases with findings are adjudicated by Board hearing panels and determinations are published on the Department of Health website.

Is this legal advice for our New York practice?

No. This is marketing guidance reviewed against current New York State Board for Medicine and OPMC rules. Consult a healthcare-marketing attorney licensed in New York and confirm any specific claim with the relevant board before publication.

Scope a New York-specific marketing compliance review

Book a 30-minute call with the ICG Global leadership, email the US practice lead, or WhatsApp us in Eastern Time. Retainers are custom-scoped per engagement · from USD ~$250/month equivalent (approx Rs 20,000).

Chat with Sr. Leadership
🎯 Goals-Driven engagements · Performance-Linked Payout Models
Chat with Sr. Leadership